Skip to content
Effetti borsistici della lotta al cancro episode artwork

Sep 14, 2026 14 min

Effetti borsistici della lotta al cancro

from Market Mover Hosted by Il Sole 24 Ore

I risultati promettenti dell’immunoterapia contro il melanoma hanno messo il turbo al titolo Moderna. Ma il rischio di eccessi è concreto

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Effetti borsistici della lotta al cancro

0:00 14:28

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Market Mover?

This episode is 14 minutes long.

When was this Market Mover episode published?

This episode was published on September 14, 2026.

Can I download this Market Mover episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.